Last month, the FDA approved another drug, known as Zepbound, as a weight loss management treatment for people with obesity, or those who are overweight with at least one related underlying condition, such as high blood pressure
CCL13 has chemoattractant activity for both human myeloid leukemia mononuclear cells and human umbilical vein endothelial cells (119)
A syringe with 0.1mL graduations makes this easier to measure accurately than trying to use an insulin syringe with its smaller volume markings
Conclusion & Next Steps For patients in Connecticut researching retatrutide in Connecticut, semaglutide, tirzepatide, or related peptide therapy, the most important takeaway is that muscle preservation should be part of the treatment conversation from the beginning
While our bodies naturally create reduced glutathione, it is not always enough for all of its functions throughout the body